Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Depression

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 95 articles:
HTML format
Text format



Single Articles


    June 2017
  1. WISE J
    Depression links to physical health decline in cancer caregivers.
    BMJ. 2017;357:j3160.
    PubMed     Text format    


  2. WISE J
    Problem solving strategy can help prevent depression in low income mothers.
    BMJ. 2017;357:j2909.
    PubMed     Text format    


    May 2017
  3. MAN KKC, Chan EW, Ip P, Coghill D, et al
    Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
    BMJ. 2017;357:j2350.
    PubMed     Text format     Abstract available


  4. WISE J
    Depression is not a risk factor for dementia, large cohort study concludes.
    BMJ. 2017;357:j2409.
    PubMed     Text format    


    February 2017
  5. MAYOR S
    Asking older people two simple questions accurately detects depression risk, study finds.
    BMJ. 2017;356:j874.
    PubMed     Text format    


    January 2017
  6. BATTY GD, Russ TC, Stamatakis E, Kivimaki M, et al
    Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies.
    BMJ. 2017;356:j108.
    PubMed     Text format     Abstract available


  7. WISE J
    CBT can benefit patients with severe depression, say researchers.
    BMJ. 2017;356:j336.
    PubMed     Text format    


  8. HAWKES N
    Sixty seconds on . . . antidepressants.
    BMJ. 2017;356:j249.
    PubMed     Text format    


    December 2016
  9. DEGNER D
    Vitamin D supplements: don't forget depression and cognitive impairment.
    BMJ. 2016;355:i6711.
    PubMed     Text format    


  10. TORJESEN I
    Irritability, fear, and anxiety often precede major depression in adolescents with high familial risk.
    BMJ. 2016;355:i6601.
    PubMed     Text format    


    November 2016
  11. MAYOR S
    One in three with mild cognitive impairment has depression, review finds.
    BMJ. 2016;355:i6387.
    PubMed     Text format    


    October 2016
  12. WISE J
    Daylight saving is linked to depression, Danish study finds.
    BMJ. 2016;355:i5857.
    PubMed     Text format    


    August 2016
  13. TWOMEY C, O'Reilly G
    Meta-analysis looks at effectiveness of MoodGYM programme in computerised cognitive behavioural therapy.
    BMJ. 2016;354:i4221.
    PubMed     Text format    


    May 2016
  14. BOURNE T
    Cutting GMC investigations must not simply devolve problems elsewhere.
    BMJ. 2016;353:i2445.
    PubMed     Text format    


    April 2016
  15. MAYOR S
    Supplements such as fish oils improve antidepressant effectiveness, review finds.
    BMJ. 2016;353:i2418.
    PubMed     Text format    


    January 2016
  16. GOODARE H
    The problem of accessing psychotherapies for depression in the UK.
    BMJ. 2016;352:i119.
    PubMed     Text format    



  17. Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial.
    BMJ. 2016;352:i195.
    PubMed     Text format    


  18. MAYOR S
    Long term opioid analgesic use is linked to increased risk of depression, study shows.
    BMJ. 2016;352:i134.
    PubMed     Text format    


  19. WISE J
    Parents' depression is linked to worse school performance in children.
    BMJ. 2016;352:i675.
    PubMed     Text format    


  20. MCCARTHY M
    US panel recommends depression screening for all adults.
    BMJ. 2016;352:i573.
    PubMed     Text format    


  21. MAYOR S
    Depression in teenagers can be identified with three questions, study shows.
    BMJ. 2016;352:i547.
    PubMed     Text format    


  22. PRINGSHEIM T, Kelly M, Barbui C
    Stopping antidepressants following depression.
    BMJ. 2016;352:i220.
    PubMed     Text format    


  23. VIGOD SN, Wilson CA, Howard LM
    Depression in pregnancy.
    BMJ. 2016;352:i1547.
    PubMed     Text format    


  24. SINYOR M, Rezmovitz J, Zaretsky A
    Screen all for depression.
    BMJ. 2016;352:i1617.
    PubMed     Text format    



  25. Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial.
    BMJ. 2016;353:i1995.
    PubMed     Text format    


  26. MCLINTOCK K, Foy R, House A, Alderson SL, et al
    A policy of universal screening for depression: caution needed.
    BMJ. 2016;353:i2174.
    PubMed     Text format    


  27. BRAILLON A, Bewley S
    Paucity of data on the safety of drugs for treating depression in pregnancy.
    BMJ. 2016;353:i2582.
    PubMed     Text format    



  28. Seven days in medicine: 9-15 January.
    BMJ. 2016;352:i153.
    PubMed     Text format    


  29. BOLTON JM, Gunnell D, Turecki G
    Authors' reply to Large.
    BMJ. 2016;532:i268.
    PubMed     Text format    


  30. LARGE M
    Study on suicide risk assessment in mental illness underestimates inpatient suicide risk.
    BMJ. 2016;532:i267.
    PubMed     Text format    


  31. CHISOLM MS, Payne JL
    Management of psychotropic drugs during pregnancy.
    BMJ. 2016;532:h5918.
    PubMed     Text format     Abstract available


  32. ENANDER J, Andersson E, Mataix-Cols D, Lichtenstein L, et al
    Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial.
    BMJ. 2016;352:i241.
    PubMed     Text format     Abstract available


  33. WISE J
    New blood test could personalise depression treatment.
    BMJ. 2016;353:i3203.
    PubMed     Text format    


  34. HAMILTON I
    Patients in trials of antidepressants are not typical of those in everyday practice.
    BMJ. 2016;352:i577.
    PubMed     Text format    


  35. AMICK HR, Gartlehner G, Gaynes BN, Lohr KN, et al
    Authors' reply to Gotzsche and Hamilton.
    BMJ. 2016;352:i617.
    PubMed     Text format    


  36. GOTZSCHE PC
    Antidepressants are addictive and increase the risk of relapse.
    BMJ. 2016;352:i574.
    PubMed     Text format    


  37. SHARMA T, Guski LS, Freund N, Gotzsche PC, et al
    Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports.
    BMJ. 2016;352:i65.
    PubMed     Text format     Abstract available


  38. MENKES DB
    Alcohol and serious harms of antidepressant treatment.
    BMJ. 2016;352:i892.
    PubMed     Text format    


  39. GOTZSCHE PC
    Author's reply to Dubicka and colleagues and Stone.
    BMJ. 2016;352:i915.
    PubMed     Text format    


  40. DUBICKA B, Cole-King A, Reynolds S, Ramchandani P, et al
    Paper on suicidality and aggression during antidepressant treatment was flawed and the press release was misleading.
    BMJ. 2016;352:i911.
    PubMed     Text format    


  41. STONE M
    Suicidality and aggression during antidepressant treatment: authors misinterpreted earlier paper from the FDA.
    BMJ. 2016;352:i906.
    PubMed     Text format    


  42. DYER C
    Judge might reopen GSK paroxetine case.
    BMJ. 2016;352:i800.
    PubMed     Text format    


  43. WISE J
    Antidepressants may double risk of suicide and aggression in children, study finds.
    BMJ. 2016;352:i545.
    PubMed     Text format    


  44. MAYOR S
    Community programme reduces depression in patients with chronic pain, study shows.
    BMJ. 2016;353:i3352.
    PubMed     Text format    


  45. MAYOR S
    Simpler psychological treatment is as effective as CBT for depression and is cheaper, study shows.
    BMJ. 2016;354:i4114.
    PubMed     Text format    


  46. COUPLAND C, Hill T, Morriss R, Moore M, et al
    Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database.
    BMJ. 2016;352:i1350.
    PubMed     Text format     Abstract available


  47. REDDY M, Rilstone S, Cooper P, Oliver NS, et al
    Type 1 diabetes in adults: supporting self management.
    BMJ. 2016;352:i998.
    PubMed     Text format    


  48. AL-JANABI H, Nicholls J, Oyebode J
    The need to "carer proof" healthcare decisions.
    BMJ. 2016;352:i1651.
    PubMed     Text format    


  49. TORJESEN I
    History of depression in grandparent and parent may raise risk of the condition.
    BMJ. 2016;354:i4431.
    PubMed     Text format    


  50. WISE J
    Number of children given antidepressants is rising, study shows.
    BMJ. 2016;352:i1457.
    PubMed     Text format    


  51. WISE J
    Hormonal contraception use among teenagers linked to depression.
    BMJ. 2016;354:i5289.
    PubMed     Text format    


    January 2015
  52. MAYOR S
    Persistent depression doubles stroke risk despite treatment, study finds.
    BMJ. 2015;350:h2611.
    PubMed     Text format    


  53. COWEN PJ
    A "fact of the matter" may not exist in scientific narratives such as serotonin and depression.
    BMJ. 2015;350:h2501.
    PubMed     Text format    


  54. KRAMER T, Als L, Garralda ME
    Challenges to primary care in diagnosing and managing depression in children and young people.
    BMJ. 2015;350:h2512.
    PubMed     Text format    


  55. LANGFORD AE
    Healy's editorial on serotonin and depression does a disservice to psychiatrists.
    BMJ. 2015;350:h2508.
    PubMed     Text format    


  56. SINYOR M, Cheung AH
    Antidepressants and risk of suicide.
    BMJ. 2015;350:h783.
    PubMed     Text format    


  57. DEGNER D
    Severe adverse reactions associated with quetiapine.
    BMJ. 2015;350:h1575.
    PubMed     Text format    


  58. DUMBRECK S, Flynn A, Nairn M, Wilson M, et al
    Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines.
    BMJ. 2015;350:h949.
    PubMed     Text format     Abstract available


  59. MARENGONI A, Onder G
    Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity.
    BMJ. 2015;350:h1059.
    PubMed     Text format    


  60. PRINGSHEIM T, Gardner D, Patten SB
    Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?
    BMJ. 2015;350:h569.
    PubMed     Text format    


  61. KALES HC, Gitlin LN, Lyketsos CG
    Assessment and management of behavioral and psychological symptoms of dementia.
    BMJ. 2015;350:h369.
    PubMed     Text format     Abstract available


  62. COUPLAND C, Hill T, Morriss R, Arthur A, et al
    Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database.
    BMJ. 2015;350:h517.
    PubMed     Text format     Abstract available


  63. TTOFI MM
    Adolescent bullying linked to depression in early adulthood.
    BMJ. 2015;350:h2694.
    PubMed     Text format    


  64. BOWES L, Joinson C, Wolke D, Lewis G, et al
    Peer victimisation during adolescence and its impact on depression in early adulthood: prospective cohort study in the United Kingdom.
    BMJ. 2015;350:h2469.
    PubMed     Text format     Abstract available


  65. THOMAS KH, Martin RM, Knipe DW, Higgins JP, et al
    Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.
    BMJ. 2015;350:h1109.
    PubMed     Text format     Abstract available


  66. FURU K, Kieler H, Haglund B, Engeland A, et al
    Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    BMJ. 2015;350:h1798.
    PubMed     Text format     Abstract available


  67. KMIETOWICZ Z
    September 11 leaves legacy of chronic ill health among US emergency medical workers.
    BMJ. 2015;350:h2032.
    PubMed     Text format    


  68. MALES MA
    Study overestimates depression due to victimisation in adolescence.
    BMJ. 2015;350:h3647.
    PubMed     Text format    


  69. CHEKROUD AM, Krystal JH
    Personalised pharmacotherapy: an interim solution for antidepressant treatment?
    BMJ. 2015;350:h2502.
    PubMed     Text format    


  70. HEALY D
    Author's reply to Langford, Cowen, Chekroud and Krystal.
    BMJ. 2015;350:h2510.
    PubMed     Text format    


  71. HAWKES N
    Young goths may be more vulnerable to depression and self harm, study finds.
    BMJ. 2015;351:h4643.
    PubMed     Text format    


  72. LE NOURY J, Nardo JM, Healy D, Jureidini J, et al
    Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
    BMJ. 2015;351:h4320.
    PubMed     Text format     Abstract available


  73. BOWES L, Joinson C, Wolke D, Lewis G, et al
    Authors' reply to Males.
    BMJ. 2015;350:h3648.
    PubMed     Text format    


  74. REEFHUIS J, Devine O, Friedman JM, Louik C, et al
    Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports.
    BMJ. 2015;351:h3190.
    PubMed     Text format     Abstract available


  75. WISE J
    Cognitive behavioural therapy shows promise in heart failure patients with depression.
    BMJ. 2015;351:h5163.
    PubMed     Text format    


  76. MERCER SW, Payne RA, Nicholl BI, Morrison J, et al
    Risk of intracranial haemorrhage linked to co-treatment with antidepressants and NSAIDs.
    BMJ. 2015;351:h3745.
    PubMed     Text format    


  77. SHIN JY, Park MJ, Lee SH, Choi SH, et al
    Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study.
    BMJ. 2015;351:h3517.
    PubMed     Text format     Abstract available


  78. BRAY BD
    Study design cannot support link between intracranial haemorrhage, antidepressants, and NSAIDs.
    BMJ. 2015;351:h4445.
    PubMed     Text format    


  79. LEWIS LS
    Combined use of antidepressants and NSAIDs: NNT for intracranial haemorrhage.
    BMJ. 2015;351:h4444.
    PubMed     Text format    


  80. MERCER SW, Payne RA, Nicholl BI, Morrison J, et al
    Authors' reply to Lewis and Bray.
    BMJ. 2015;351:h4446.
    PubMed     Text format    


  81. ZHANG MW, Ho RC
    Ketamine's potential as a rapid antidepressant was overplayed.
    BMJ. 2015;351:h4467.
    PubMed     Text format    


  82. DOWRICK C
    Computerised self help for depression in primary care.
    BMJ. 2015;351:h5942.
    PubMed     Text format    


  83. GILBODY S, Littlewood E, Hewitt C, Brierley G, et al
    Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial.
    BMJ. 2015;351:h5627.
    PubMed     Text format     Abstract available


  84. VAN DER AA HP, van Rens GH, Comijs HC, Margrain TH, et al
    Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial.
    BMJ. 2015;351:h6127.
    PubMed     Text format     Abstract available


  85. SINYOR M, Fefergrad M, Zaretsky A
    Cognitive behavioural therapy or antidepressants for acute depression?
    BMJ. 2015;351:h6315.
    PubMed     Text format    


  86. DE VRIES YA, Turner EH, Roest AM
    Retraction of biased journal articles.
    BMJ. 2015;351:h5497.
    PubMed     Text format    


  87. TRAVASSO C
    Maharashtra government launches mental health programme to reduce suicide in farmers.
    BMJ. 2015;351:h5234.
    PubMed     Text format    


  88. SASICH LD
    Paroxetine and Study 329: what we already knew and when.
    BMJ. 2015;351:h5411.
    PubMed     Text format    


  89. LE NOURY J, Nardo JM, Healy D, Jureidini J, et al
    Authors' reply to Sasich and Linden.
    BMJ. 2015;351:h5412.
    PubMed     Text format    


  90. LINDEN DE
    Restoring Study 329: results differ with the adverse event classification system used.
    BMJ. 2015;351:h5413.
    PubMed     Text format    


  91. DOSHI P
    No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility.
    BMJ. 2015;351:h4629.
    PubMed     Text format    


  92. AMICK HR, Gartlehner G, Gaynes BN, Forneris C, et al
    Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
    BMJ. 2015;351:h6019.
    PubMed     Text format     Abstract available


  93. BOLTON JM, Gunnell D, Turecki G
    Suicide risk assessment and intervention in people with mental illness.
    BMJ. 2015;351:h4978.
    PubMed     Text format     Abstract available


  94. KHALIFEH H, Dolman C, Howard LM
    Safety of psychotropic drugs in pregnancy.
    BMJ. 2015;350:h2260.
    PubMed     Text format    


    January 2014
  95. KMIETOWICZ Z
    NICE advises extra pregnancy support for women at risk of mental health problems.
    BMJ. 2014;349:g7720.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: